1. Case History66 year old man complains of:Epigastric pain which has gradually increased for the past two monthsLoss of appetite (anorexia)Early satietyWeight loss of 5…

1. Can we predict it ? Late metastasis Joseph  Gligorov  MD,  PhD   ESO  Advanced  Breast  Cancer  Task  Force   APHP-­‐HUEP-­‐Tenon,  Paris   InsDtut  Universitaire…

Molecular mechanism of cancer metastasis Dr. Yick-Pang Ching Department of Pathology Room L7-05, Faculty Medicine Building Tel: 28199656 E.Mail: [email protected] 1 Overview…

LUNG AND MEDIASTINAL CANCER 1. LUNG CANCER 2. MEDIASTINAL CANCER AHMAD RASYID Sub Bagian Pulmonologi Bagian Ilmu Penyakit Dalam RS. Moh.Hoesin / FK Unsri 1.LUNG CANCER HISTOLOGICAL…

1. MUC1 as a biomarker for TGFβ1 inhibition: Investigating the role of MUC1 in the switch of TGF-β1 function from a tumor suppressor to a tumor promoter in pancreatic ductal…

1. Dr. JIGYASA SHAHANIModerator: Dr. FAREED AHMED 2.  -Term given to an embryologically related groupof tumours of endocrine organs. They are believed to arise from…

PREPARED BY: AILYN ANTOQUE Breast cancer • is a cancer that starts in the cells of the breast in women and men. • Most commonly occurring in women and second leading…

Molecular Pathology of Prostate CancerMolecular Pathology of Prostate Cancer Ibrahim Kulac, MDa, Martine P. Roudier, MD, PhDb, Michael C. Haffner, MD, PhDc,d,e,f,* Key points

Therapeutic strategies in RET gene rearranged non-small cell lung cancerREVIEW Therapeutic strategies in RET gene rearranged non-small cell lung cancer Leylah M. Drusbosky1,

11 (CC2015).inddP rostate cancer (PCa) is diagnosed based on the measurement of the patient’s serum prostate-spe- cific antigen (PSA) level and the results of a digital